CLIRLIVIE
LIVE

Serial Number

98881013

Owner

Corcept Therapeutics Incorporated

Attorney

Joel R. Feldman

Filing Date

Dec 2, 2024

Add to watchlist:

No watchlists yet
View on USPTO

CLIRLIVIE Trademark

Serial Number: 98881013

CLIRLIVIE is a trademark filed by Corcept Therapeutics Incorporated on December 2, 2024. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Corcept Therapeutics Incorporated (3 trademarks)

101 Redwood Shores Parkway, 3rd Floor
Redwood City, CA 94065

Entity Type: 03

Trademark Details

Filing Date

December 2, 2024

Registration Date

Not Registered

Published for Opposition

July 1, 2025

Goods & Services

Pharmaceutical preparations for the treatment of endocrine diseases and disorders; pharmaceutical preparations for the treatment of psychiatric and neurological diseases and disorders; pharmaceutical preparations for the treatment of Cushing's syndrome and Cushing's disease; pharmaceutical preparations for the treatment of cancer, liver disorders, oncologic, endocrine, metabolic, cardiovascular, ophthalmic, and gastroenterologic diseases and disorders

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 25, 2026 EXRA
SOU EXTENSION 2 GRANTED
Jul 24, 2026 EX2G
SOU EXTENSION 2 FILED
Jul 24, 2026 EXT2
SOU TEAS EXTENSION RECEIVED
Jul 24, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 13, 2026 EXRA
SOU EXTENSION 1 GRANTED
Jan 12, 2026 EX1G
SOU EXTENSION 1 FILED
Jan 12, 2026 EXT1
SOU TEAS EXTENSION RECEIVED
Jan 12, 2026 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Aug 26, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 1, 2025 NPUB
PUBLISHED FOR OPPOSITION
Jul 1, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 25, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 28, 2025 CNSA
ASSIGNED TO EXAMINER
May 21, 2025 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
May 15, 2025 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 15, 2025 NWOS
NEW APPLICATION ENTERED
Dec 2, 2024 NWAP